FDA Inspection
Biovex, Inc.Biovex, Inc. – FDA Inspection, Mar 16, 2017
Record Details
This FDA Inspection record concerns Biovex, Inc., with an inspection on March 16, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ef59841b-155c-4ce8-b081-c990d3d6d0aa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012905
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
Other FDA inspections of Biovex, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 27, 2019 | Not classified | New England District Office |
Other documents for Biovex, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.